HealthStream’s Legacy Revenue Fades as AI and Data Drive Growth

Date of Call: Feb 24, 2026

Financials Results

• Revenue: Q4: $79.7M, up 7.4% YOY; Full Year: up 4.3% YOY
• EPS: Q4: $0.09 per share, down from $0.16 per share YOY; Adjusted EBITDA: $18.8M, up 16.4% YOY
• Gross Margin: 63.8% compared to 66.2% in the prior year quarter
• Operating Margin: Operating income was $2.4M, down 48.8% YOY; Non-GAAP operating income was $6.2M, up 31.7%

Guidance:

• Revenue for 2026 expected between $323M and $330M, representing growth of 6.2% to 8.5%.
• Q1 revenue growth rate estimated at approximately 8%.
• Quarterly revenues expected to improve sequentially across the year.
• Net income expected between $20.4M and $22.8M.
• Adjusted EBITDA expected between $73M and $77M.
• Capital expenditures expected between $31M and $34M.
• Effective tax rate expected approximately 22%.
• Inorganic revenue contribution expected to be approximately $13M for the year.

Business Commentary:

Revenue and Financial Performance:

• HealthStream reported revenue of $79.7 million for the fourth quarter, up 7.4% year-over-year.
• Adjusted EBITDA increased by 16.4% to $18.8 million.
• The growth was driven by strong performance in core solutions, particularly Credential Stream and ShiftWizard, and contributions from recent acquisitions.

User Base Expansion and AI Impact:

• The number of health care providers, especially nurses, is projected to increase, with health care accounting for approximately 82,000 of the 130,000 new jobs added in the U.S. in January 2026.
• AI is seen as enhancing the roles of nurses by automating paperwork, allowing more patient contact.
• The expansion of the health care user base and AI integration are expected to drive future growth.

Platform and Data Strategy:

• HealthStream's platform strategy emphasizes interoperability, with AI as one of ten core elements.
• The company's systems, such as in learning and credentialing, serve as a system of record, which is critical for AI reliance.
• This strategic positioning enhances customer value by providing a single source of truth for workforce data.

Career Networks and Data Origination:

• HealthStream's career networks, such as NurseGrid, are growing, with NurseGrid adding about 2,000 new nurses weekly and having over 670,000 monthly active users.
• The origination of proprietary data through these networks provides valuable insights for workforce management.
• This data is beneficial for managing the health care workforce and integrates with HealthStream's platform.

Legacy Product Transition:

• Revenues from legacy credentialing and scheduling applications declined by 27% compared to the previous year.
• The transition to newer applications like Credential Stream and ShiftWizard is underway, with customers migrating to these platforms.
• The focus is on encouraging legacy customers to transition to newer, more integrated solutions to enhance performance and features.

Sentiment Analysis:

Overall Tone: Positive

• CEO states 'HealthStream is positioned for another exciting year' and highlights strong growth in user base and AI positioning. CFO notes 'exciting events' including acquisitions and share repurchases, and expresses confidence in delivering 'another solid year of financial performance.' Management emphasizes record revenues, growth in core solutions, and a strong cash position.

Q&A:

• Question from Matthew Hewitt (Craig-Hallum Capital Group): What are the margins for Mission Care and is there opportunity to lift them to corporate average?
  Response: Management does not report product-level margins but notes all legacy products are being pushed for higher margins and are a focus for migration to newer applications.

• Question from Matthew Hewitt (Craig-Hallum Capital Group): Are there M&A opportunities with other platforms being pulled into HealthStream's platform, and does this highlight stickiness?
  Response: Management emphasizes that being a system of record provides relative strength; customers are integrating third-party data into HealthStream's platform, indicating its central role and stickiness.

• Question from Constantine Davides (Citizens): What interoperability features are resonating most with customers between my clinical exchange and the rest of the platform?
  Response: An example is a widget connecting clinical students in rotations with hospital managers to facilitate recruiting, demonstrating data flow across the platform that provides a competitive advantage.

• Question from Constantine Davides (Citizens): How much legacy revenue is left and at what point do you consider a sunsetting strategy?
  Response: Legacy revenue is approximately 10% of total (~$30M+), with no forced sunset currently; migration is encouraged as newer applications offer more value and platform integration.

• Question from Ryan Daniels (William Blair): Does data origination change capital deployment for AI and M&A?
  Response: Yes, capital is flowing into AI development and data management as part of the platform strategy, with increased focus on organizing and classifying data.

• Question from Ryan Daniels (William Blair): Are sales seeing hesitation due to AI or pricing, or is it business as usual?
  Response: Q4 was exceptionally strong with large deals, indicating no significant hesitation; sales focus on educating the market about the platform and value proposition.

• Question from Richard Close (Canaccord Genuity): What were the acquisition contributions in Q4 and for 2026 guidance?
  Response: The two acquisitions contributed $1.6M in Q4 and are expected to contribute ~$13M for the full year 2026.

• Question from Richard Close (Canaccord Genuity): Can you provide examples of integrating Gen AI into offerings?
  Response: AI is part of the platform roadmap for all products, with work on agentic frameworks, vector analysis for profiles, and workflow automation; details will unfold through the year.

• Question from Richard Close (Canaccord Genuity): What are conversations with health system executives revealing about AI budgets and systems of record?
  Response: Executives are focused on consolidating point solutions and solving business problems like nursing shortages; AI dialogue is secondary to value propositions such as onboarding efficiency and cost management.

• Question from Vincent Colicchio (Barrington Research): How are price accelerators playing out?
  Response: Inflationary escalators, now standard in contracts, are having a financial impact and help smooth budgeting for customers, though the effect is slow due to contract renewal cycles.

Contradiction Point 1

Legacy Revenue Projections and Migration Strategy

Timeline for sunset of legacy products appears to have shifted, impacting financial outlook and customer migration plans.

What are your thoughts on Citizens' recent earnings performance? - Constantine Davides (Citizens)

20260224-2025 Q4: Legacy revenues... are approximately 10% of total revenue (~$30 million). The company is focusing on migrating customers to newer applications... Products will be evaluated for 'sunset' status in the future, giving customers a planned transition period. - Robert Frist(CEO)

Which interoperability features under the career network strategy are driving the most customer interest? What remains of legacy revenue, and when will a sunsetting strategy be considered? - Richard Close (Canaccord Genuity Corp.)

2025Q3: Monetization strategies are in early stages but include: 1) Direct sales of education credits in NurseGrid Learn (~$40k/month)... - Robert Frist(CEO)

Contradiction Point 2

AI Integration and Product Monetization

Focus on AI's role shifts from a core platform element to a facilitating tool, altering the strategic emphasis on product value proposition.

What are your key takeaways from the recent earnings report? - Ryan Daniels (William Blair)

20260224-2025 Q4: AI is one of ten core elements of the HealthStream platform, and internal development is focused on integrating AI into products. - Robert Frist(CEO)

Does prioritizing data origination alter capital allocation strategies for internal development or M&A? Are CTOs hesitant about long-term contracts, pricing increases, or AI integration impacting sales? - Matthew Hewitt (Craig-Hallum Capital Group LLC)

2025Q3: The business model has evolved from a lower-margin 'razor blade' strategy (selling third-party content) toward higher-margin SaaS and PaaS applications... The trajectory is upward due to the increasing mix of new, higher-margin products (e.g., CredentialStream, ShiftWizard, career networks). - Robert Frist(CEO)

Contradiction Point 3

Gross Margin Outlook

Expectations for gross margin recovery timeline and current pressures differ significantly between quarters, affecting financial forecasting.

Can you discuss your outlook for revenue growth in the current quarter? - Matthew Hewitt (Craig-Hallum Capital Group)

20260224-2025 Q4: Blended gross margin compression is due to increasing cost of goods for some application suites, not acquisitions. The company is conducting an RFP to consolidate hosting services. - Robert Frist(CEO)

What are the margins of the $13 million inorganic revenue from Mission Care Collective in 2026, and is there potential to align them with the corporate average for margin improvement? - Matthew Hewitt (Craig-Hallum)

2025Q2: Gross margins are expected to hover around the 65% mark for the remainder of the year. It will take a few quarters to return to previous levels. - Scott Roberts(CFO)

Contradiction Point 4

Legacy Product Revenue Impact

The remaining legacy revenue and its near-term impact on growth are presented differently, creating uncertainty about future financial performance.

What is Constantine Davides' (Citizens) role in the earnings call? - Constantine Davides (Citizens)

20260224-2025 Q4: Legacy revenues... are approximately 10% of total revenue (~$30 million). The company is focusing on migrating customers to newer applications... Products will be evaluated for 'sunset' status in the future. - Robert Frist(CEO)

(1) Which interoperability features of the career network strategy are most resonating with customers and prospects? (2) How much legacy revenue remains after a 27% decline, and when will a sunsetting strategy be considered? - Richard Close (Canaccord Genuity)

2025Q2: The $1.8 million decline from legacy products... The decline rate for legacy products is such that in a couple of more quarters, their negative impact will be significantly less material... - Robert Frist(CEO)

Contradiction Point 5

Pricing Escalator Adoption

The adoption and standardization of price escalators is described as complete in the newer quarter but was still being implemented in the previous one, affecting revenue predictability.

What were the key takeaways from the earnings call? - Vincent Colicchio (Barrington Research)

20260224-2025 Q4: The escalator mechanism, now standard across all major application suites, is working as intended. - Robert Frist(CEO)

Are the annual pricing escalators performing as expected? - Vincent Colicchio (Barrington Research)

2025Q2: Price escalators are now officially being worked into every new and renewed contract across all business units... This model is being applied consistently. - Robert Frist(CEO)